Article
Glucocorticoid receptor inhibition enables tumor-infiltrating macrophages to overcome immunotherapy resistance in advanced melanoma
2025-12-29
Abstract excerpt
<title>Abstract</title> <p>Immune-checkpoint inhibitors (ICIs) benefit patients with advanced melanoma, yet resistance remains common and the myeloid circuits that limit response are incompletely defined. We identify glucocorticoid receptor (GR) signaling in tumor-associated macrophages (TAMs) as a druggable brake on antitumor immunity under PD 1 blockade. Myeloid-specific GR deletion restored immune recognition...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- b8df0ff3-1f19-5f92-8afe-b455310bdc0a
- DOI
- 10.21203/rs.3.rs-8378434/v1
